Ikarian Capital’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,798
| Closed | -$75K | – | 167 |
|
|
2024
Q4 | $75K | Sell |
6,798
-18
| -0.3% | -$199 | 0.01% | 112 |
|
|
2024
Q3 | $83.8K | Hold |
6,816
| – | – | 0.01% | 93 |
|
|
2024
Q2 | $92.1K | Hold |
6,816
| – | – | 0.02% | 82 |
|
|
2024
Q1 | $92K | Sell |
6,816
-5,300
| -44% | -$71.6K | 0.01% | 75 |
|
|
2023
Q4 | $63.7K | Hold |
12,116
| – | – | 0.01% | 73 |
|
|
2023
Q3 | $47.7K | Sell |
12,116
-58,274
| -83% | -$230K | 0.01% | 75 |
|
|
2023
Q2 | $748K | Buy |
+70,390
| New | +$748K | 0.12% | 51 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 81 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 116 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 190 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 220 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 234 |
|